by The anastomosis devices market involves products that are used to perform anastomoses during open as well as minimally invasive surgeries. Surgical staplers, surgical sutures, and surgical sealants & adhesives are some commonly used anastomosis devices. Surgeons utilize these devices to join tissues and organs in complex reconstructive procedures including cardiac, thoracic, and gastrointestinal surgeries. Anastomosis devices help to minimize tissue trauma and prevent complications associated with traditional hand-sewn anastomoses.
The Global Anastomosis Devices Market is estimated to be valued at US$ 25.81 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Anastomosis Devices Market Demand are AGSCO Corporation, Carborundum Universal Ltd., Entegris Inc. ESD-SIC b.v., ESK-SIC GmbH, Gaddis Engineered Materials, Grindwell Norton Ltd., Norstel AB, Saint-Gobain Ceramics Materials GmbH, and Snam Abrasives Pvt. Ltd. The demand for anastomosis devices is growing significantly owing to the rising adoption of minimally invasive surgeries globally. Leading manufacturers are focusing on expanding their product portfolios and geographical presence to strengthen their market shares in high growth regions.
Market key trends
One of the key trends witnessed in the anastomosis devices market is the growing preference for laparoscopic procedures over open surgeries. Traditionally, complex anastomoses were performed using hand-sewn sutures during open surgeries. However, technological advances have enabled the development of automated, stapling devices compatible with minimally invasive surgery. This has boosted the adoption of laparoscopic surgeries including gastrointestinal and cardiothoracic procedures worldwide.
Porter’s Analysis
Threat of new entrants: The huge capital investment required for production facilities and R&D activities poses a high barrier for new players. Bargaining power of buyers: Individual buyers have low bargaining power due to wide availability of substitutes however bulk buyers can negotiate on prices. Bargaining power of suppliers: The suppliers of raw materials have moderate bargaining power as anastomosis devices require specialized raw materials and components with stringent quality standards. Threat of new substitutes: Substitutes like vascular staplers and suturing pose minimal threat as anastomosis devices offer advantages like precision and consistency. Competitive rivalry: The industry players compete on the basis of product innovation, quality, and after sales service to maintain market share.
North America accounts for the major share of the anastomosis devices market due to rise in prevalence of target diseases, growing healthcare expenditure, availability of advanced healthcare infrastructure and reimbursement policies. The United States holds the largest share and is expected to maintain its dominance during the forecast period owing to presence of key players, developed healthcare system and large patient population.
Asia Pacific is poised to grow at the fastest rate during the forecast period on account of rapidly developing healthcare infrastructure, rise in medical tourism, growing middle class population and increasing healthcare expenditure in countries such as India and China. Growing awareness regarding availability of advanced treatment options, improving accessibility and affordability will fuel the demand for anastomosis devices in Asia Pacific region.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
